C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/37 (2006.01)
Patent
CA 2466497
The present invention concerns a further development and use of biological assays to determine the amount or concentration of an active ingredient present in a sample. The enzyme assay of the present invention determines the amount or concentration of protease inhibitors, including retroviral protease inhibitors such as HIV inhibitors.
L'invention concerne un développement supplémentaire et l'utilisation de systèmes d'analyse biologique destinés à déterminer la quantité ou la concentration d'un principe actif présent dans un échantillon. Le système d'analyse d'enzyme de cette invention détermine la quantité ou la concentration d'inhibiteurs de protéase, notamment des inhibiteurs de protéase rétroviraux, tels que des inhibiteurs VIH.
Erickson John W.
Gulnik Sergei
Markowitz Martin
Yu Betty
Aaron Diamond Aids Research Center
Gowling Lafleur Henderson Llp
The Rockefeller University
Tibotec Pharmaceuticals Ltd.
LandOfFree
Protease assay for therapeutic drug monitoring does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Protease assay for therapeutic drug monitoring, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Protease assay for therapeutic drug monitoring will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1743714